1-(4-Nitrophenyl)cyclobutanecarbonitrile, 97.0%, 1g

4-tert-Butyl-4'-ethylbenzophenone, 97.0%, 1g

{[3-(4-tert-butylphenyl)-1,2,4-oxadiazol-5-yl]methyl}amine hydrochloride, 95.0%, 1g

2-Methyl-6-phenylpyridine, 95.0%, 100mg

2-Acetamidophenyl acetate, 250mg

1,2,3,7,8,9-hexahydrocyclopenta[d]cyclopenta[3,4]pyrazolo[1,5-a]pyrimidin-6-amine, 95.0%, 1g

2-Amino-9-(((1,3-dihydroxypropan-2-yl)oxy)methyl)-1H-purin-6(9H)-one, 95.0%, 10g

Récipient de réaction à bride plate cylindrique, gradué (1) Fond rond, DN 150, 160 mm, Hauteur, 210 mm, 1 Pièce

Ethyl 6-bromo-4-chloro-8-methylquinoline-3-carboxylate, 98%, 100mg

(S)-(-)-4-Amino-2-hydroxybutyric Acid>98.0%(T)25g

N-(Azetidin-3-yl)methanesulfonamide hydrochloride, 95.0%, 100mg

3,5-Difluorobenzoylacetonitrile, 96.0%, 1g

methyl 2-methyl-3-{[2-(morpholin-4-yl)ethyl]amino}propanoate, 95.0%, 2g